To Be Discontinued Tablet Neurology

Baclofen Tablet · 12 active FDA presentation rows for this drug

Brand: BACLOFEN

FDA lists Baclofen Tablet as To Be Discontinued (Upsher-Smith Laboratories, LLC).

No availability text on this FDA row.

Baclofen Tablet: To Be Discontinued

FDA availability text is not recorded on this row. 12 shortage presentations are tracked for this drug. Contact your pharmacist if you are affected.

Shortage Details

Generic Name
Baclofen Tablet
Manufacturer
Upsher-Smith Laboratories, LLC
Dosage Form
Tablet
Presentation
Baclofen, Tablet, 20 mg (NDC 0832-1055-11)
Package NDC
0832-1055-11

Status & Timeline

Status
To Be Discontinued
First Reported
Apr 23, 2025
Last Updated
Apr 23, 2025
Therapeutic Category
Neurology

Row fields from the FDA Drug Shortages database via openFDA.

Full Drug Profile

baclofen

Side effects, interactions, warnings & more

View Profile
Compare baclofen with alternatives →

Nearby, Other Baclofen Shortage Records

Baclofen Tablet

Upsher-Smith Laboratories, LLC

Tablet

To Be Discontinued

Baclofen Tablet

Upsher-Smith Laboratories, LLC

Tablet

To Be Discontinued

Baclofen Tablet

Upsher-Smith Laboratories, LLC

Tablet

To Be Discontinued

Baclofen Tablet

Upsher-Smith Laboratories, LLC

Tablet

To Be Discontinued

Baclofen Tablet

Upsher-Smith Laboratories, LLC

Tablet

To Be Discontinued

Baclofen Tablet

Upsher-Smith Laboratories, LLC

Tablet

To Be Discontinued
← All Drug Shortages